Changes in QTc Interval and QT Dispersion due to Incremental Atrial Pacing in Patients with Ventricular Tachyarrhythmia

Size: px
Start display at page:

Download "Changes in QTc Interval and QT Dispersion due to Incremental Atrial Pacing in Patients with Ventricular Tachyarrhythmia"

Transcription

1 Showa Univ J Med Sci 14(4), , December 2002 Original Changes in QTc Interval and QT Dispersion due to Incremental Atrial Pacing in Patients with Ventricular Tachyarrhythmia Taro ADACHI, Youlchl KOBAYASHI, Mltsuharu KAWAMURA, Shunsho RYU, Taku ASANO, Chiaki OBARA, Jotaro SHINAGAWA, Aklra MIYATA, Kaoru TANNO, Shuji KIKUSHIMA, Takao BABA and Takashl KATAGIRI Abstract : This study was conducted to establish the relationship between QT dispersion and QT duration due to incremental atrial pacing. The QT interval and dispersion were measured in 47 patients. Sixteen of the patients had ventricular tachycardia or ventricular fibrillation (VT/ VF) [10 with organic heart disease (OHD) and 6 without OHD ]. The control group was 31 patients (15 with OHD and 16 without OHD). The QT interval was measured from a surface 12-lead electrocardiogram in sinus rhythm and during incremental atrial paced rates, and was calculated using Bazett's formula. Moreover, the QT interval was divided into the interval between the onset of the QRS and the peak of the T wave (QT peak) and the interval between the peak of the T wave and the end of the T wave (QT end). QT dispersion at rest was markedly increased in the VT/ VF with OHD group compared with that in the controls and the VT/ VF without OHD group (172 } 97.2 vs 78 } 41.1 vs 56.7 } 39.3 vs 52.5 } 25.9 p < 0.05). In VT/ VF patients with OHD, QT dispersion decreased up to 100 beats per minute (bpm) due to the incremental atrial pacing, but increased beyond 100 bpm. The QTc minimum (QTc min) interval did not change with any of the pacing rates. The interval between QT peak and QT end is a nucleus of the fluctuation of the dispersion by the heart rate. The QT dispersion of the VT/ VF with OHD patient group responded to heart rate changes. Key words : QT interval, QT dispersion, atrial pacing, ventricular tachyarrhythmia Introduction The QT interval is a traditional electrocardiographic parameter of the duration of ventricular repolarization. Prolongation of the QT interval is an indicator of an increased risk of ventricular tachyarrhythmias in various clinical conditions. Increased spatial and temporal dispersion of repolarization is believed to be important in the genesis of ventricular arrhythmiasl). Day et al2) suggested that the interlead difference in QT intervals, which they call the "QT dispersion", may provide the inhomogeneity in ventricular repolarization. Dispersion of repolarization is considered to be an important electrophysiological factor for Third Department of Internal Medicine, Showa University School of Medicine, Hatanodai, Shinagawa-ku, Tokyo , Japan.

2 272 Taro ADACHI, et al the initiation of ventricular fibrillation (VF). Recently, Sporton et al reported that inducible QT dispersion by incremental atrial pacing is a more useful indicator than resting QT dispersion in patients with coronary artery disease3). QT dispersion changes depending upon atrial pacing rates in OHD with ventricular tachyarrhythmia have not been examined. The aim of this study was to investigate differences in the QT dispersion induced by incremental atrial pacing between OHD patients with or without lethal ventricular tachyarrhythmias. Methods Patients Forty-seven consecutive patients undergoing electrophysiological study (EPS) were studied. Sixteen patients had suffered from ventricular tachycardia (VT) or VF. Thirty-one patients had paroxysmal supraventricular tachycardia (PSVT). These patients were examined by chest X-ray, echocardiogram including doppler image, coronary angiography and left ventricular angiography. None of the patients received any drugs during the EPS. Patients with atrial fibrillation, bundle branch block and unmeasurable T waves were excluded. Informed consent was obtained from all subjects. Electrophysiological study Programmed ventricular stimulation was performed at the right ventricular apex or outflow tract at cycle lengths of 600 or 400 ms. A train-of-seven S 1 stimuli were presented, followed by up to 3 consecutive extra stimuli and burst pacing with the introduction of VT or VF. Patients were judged to be noninducible if VT could not be induced with 3 extra stimuli and burst pacing from at least 2 right ventricular sites. Next, a multipolar pacing catheter was placed high in the right atrium. The first ECG was recorded at rest, and then atrial pacing was started; the initial pacing interval was just above each individual patient's heart rate. The pacing rate was increased in increments of 10 bpm at 3-min intervals until the appearance of atrioventricular (AV) block. QT interval measurements All measurements were made by 2 observers who were blinded to the patients' details and the average values were adopted. The QT interval was measured visually on surface electrocardiograms at a paper-speed of 50 mm/sec and amplitude of 20 mv/cm. The QT interval was taken from the onset of the QRS complex to the end of the T wave, which was defined as a return to the P-P baseline. If a U wave was present, the end of the QT interval was defined as the nadir of the T wave. When the end of the QT interval could not be identified with certainty, the lead was excluded from the analysis. At least 9 measurable leads were required from each electrocardiogram (ECG) recording. The QT dispersion was defined as the absolute value of the difference between the maximum and minimum QT interval in any of the measurable leads. The QT intervals were corrected using a modified version of Bazett's formula4) (QTc=QT/[RR) to obtain the corrected QT interval (QTc) in each lead and hence QTc dispersion. Moreover, in all leads the QT peak interval, (the interval between the start of the QRS and the peak of the T wave), and the QT peak-end interval, (the interval between the peak of the T wave and the end of the T wave) were measured. The QT peak dispersion and QT peak-end dispersion were

3 QT Alteration by Atrial Pacing 273 Table 1. Clinical characteristics of the study population OHD with VT/VF group : OMI 6, DCM 2, HCM 2 OHD without VT/VF group : OMI 7, DCM 3, DCM 3, Cardiac sarcoidosis 1, AR 1 OHD : Organic heart disease ; OMI : Old myocardial infarction ; DCM : Dilated cardiomyopathy ; HCM : Hypertrophic cardiomyopathy ; AR : Aortic regurgitation calculated in the same manner. Respective dispersion was measured in any of the 12 leads, and was further corrected for the effects of heart rate. Statistical analysis One-way analysis of variance (one-way ANOVA) was used to compare the groups. value <0.05 was considered significant. A p Results The clinical features of the patients are shown in (Table 1). The study group consisted of 34 men and 13 women with a mean age of 59 }15 years (range, years). Sixteen patients had suffered VT or VF as the first clinical manifestation of ventricular arrhythmia (VT/VF group). Six patients of the VT/ VF group had no OHD and the remaining 10 patients had OHD. This included 6 patients with old myocardial infarction (OMI ), 2 patients with dilated cardiomyopathy (DCM) and two with hypertrophic cardiomyopathy ( HCM). Thirty-one patients with PSVT were used as controls (control group). Sixteen patients in the control group had no OHD and the remaining 15 had OHD. This included 7 patients with OMI, 3 patients with DCM, 3 patients with HCM, 1 patient with cardiac sarcoidosis and 1 patient with aortic regurgitation (AR). In summary, 62.5% of patients in the with VT/VF group had OHD and 48.4% in the without VT/VF group had OHD. QT interval and QT dispersion at rest The resting values of the QT dispersion are shown in Fig. 1. The QT dispersion was significantly longer in the OHD with VT/VF group (172 ± 97.2 msec) than in the other 3 groups (OHD without VT/VF, 78±41.1, p<0.01; no OHD with VT/VF, 56.7 }39.3, p< 0.01; no OHD without VT/VF, 53 ± 25.9, p< 0.001). The QT peak dispersion and QT peak-end dispersion also tended to be larger in the OHD with VT/ VF group than in the other 3 groups. QT dispersion in the no OHD with VT/ VF group was almost in the normal range, similar to the without VT/VF group. The mean QT dispersion in the OHD with VT/VF group was prolonged at each pacing rate. (Fig. 2) shows the QTc maximum and minimum at rest. The QTc minimum in the OHD with VT/VF group was not significantly different from the other groups. In contrast, a significant difference in QTc

4 274 Taro ADACHI, et al Fig. 1. QT dispersion at rest Fig. 2. QTc max and min at rest maximum was found between the OHD with VT/VF group (620.8 ±93.3 msec) and each of the other groups (OHD without VT/VF, 499.4±41.3, p<0.001; no OHD with VT/VF, ±42.7, p<0.01; no OHD without VT/ VF, 460.0± 42.7, p<0.001). Response of QT interval and dispersion to pacing rate The changes in QT dispersion are presented in Fig. 3. In the OHD with VT/VF group, the QT dispersion decreased with atrial pacing of 70 to 100, but then increased from 110 bpm. Fig. 4 shows that the QT peak dispersion did not change in any of the 4 groups with an alteration in heart rate. Therefore, QT dispersion depends on QT peak-end dispersion (Fig. 5). Fig. 6 shows the QTc maximum (QTc max) and QTc min for each pacing rate in the OHD with VT/VF group. QTc min shows a statistical change at each pacing rate.

5 QT Alteration by Atrial Pacing 275 Fig. 3. Effect of incremental atrial pacing on QT dispersion Fig. 4. Effect of incremental atrial pacing on QT peak dispersion In contrast, QTc max decreased up to 100 bpm, but increased at 110 bpm. Fig. 7 shows the relationship between pacing-induced changes in QT dispersion in OMI patients with VT/VF and non-ischemic patients with VT/VF. There were no significant differences in QT dispersion between OMI patients with VT/VF and non-ischemic patients with VT! VF. Fig. 8 shows the relationship between pacing-induced changes in QT dispersion in patients with VT/ VF and in OMI patients with non-vt/ VF. In VT/ VF group, the QT dispersion increased from 70 bpm to 80 bpm, but decreased from 80 bpm to 100 bpm, and then increased again from 100 bpm to 120 bpm. However, in patients with non-vt/ VF in OMI, the QT dispersion increased from 70 bpm to 80 bpm, but then decreased from 80 bpm. The QT dispersion was significantly longer in the patients with VT/VF in OMI group than the patients with non-vt/vf in OMI group in 70 bpm and 80

6 276 Taro ADACHI, et al Fig. 5. Effect of incremental atrial pacing on QT peak-end dispersion Fig. 6. Effect of incremental atrial pacing on QTc max and QTc min bpm (70 bpm ; VT/ VF in OMI, } 35.1 ms, non-vt/vf in OMI, 67.5 } 27.5 ms, p < 0.05, 80 bpm ; VT/ VF in OMI, } 44.4 ms, non-vt/vf in OMI, 78.6 } 28.5 ms, p<0.01). Discussion It has been reported that the QT interval can identify developing ventricular arrhythmias in long QT syndrome2, 5, 6) hypertrophic cardiomyopathy'' 8) and congestive heart failure9-'11). However, QT dispersion did not predict the occurrence of ventricular arrhythmia early after the onset of acute myocardial infarction12,13), or fatal arrhythmia in the chronic phase of myocardial infarction 14). Exercise or atrial pacing induced QT dispersion and / or QT

7 QT Alteration by Atrial Pacing 277 Fig. 7. Relation between pacing induced changes in QT dispersion in OMI patients with VT/VF and in non-ischemic patients with VT/VF Fig. 8. Relation between pacing-induced changes in QT dispersion in patients with VT/VF and in OMI patients with non-vt/vf duration with a relatively rapid heart rate have been used to identify patients with coronary artery disease3,ls). Several studies have shown that the action potential duration shortens in ischemia 16,17) This study has shown that QT dispersion and QT duration in the VT/ VF group with OHD was longer than in the other groups at a resting heart rate. In addition, QT dispersion on each incremental atrial pacing rate gave similar results. It was interesting that the QT dispersion in the VT/VF group with OHD decreased up to 100 bpm, and then increased at 110 bpm. QTc min did not change significantly during incremental atrial pacing of the heart rate. In contrast, QTc max decreased up to 100 bpm of atrial pacing and increased at 110 bpm. Several studies have demonstrated that the absence of QT interval shortening during exercise could be a sensitive marker of coronary artery disease18-20). Gang

8 278 Taro ADACHI, et al Yi et al observed that exercised-induced prolongation of the QTc interval differentiates patients at high risk of sudden cardiac death from those at low risk. A possible explanation is that ventricular repolarization fails to adapt normally to increases in heart rate in sudden death patients21). It was thought that the OHD with VT/VF group was adaptable to 100 bpm, but that the QTc max could not be adapted from 110 bpm. Study limitations Bazett's formula Zabel et al measured action potential duration90 (APD90) and recovery time (RT) in simultaneous MAP recordings in 18 isolated Langendorff-perfused rabbit hearts22). APD90 and RT shortened continuously throughout all pacing rates, but dispersion of APD90 and RT did not change significantly. Thus, a rate correction of dispersion of repolarization may not be necessary and may even distort the values (and the predictive value) of QT dispersion. The major weakness of Bazett's formula, which is used to correct the QT interval for the influence of heart rate, is that it makes the adjustment unreliable at slow and fast rates as these are based on the predominant heart rates in the studied populations23, 24) However, the correction was used uniformly in all leads within the 4 groups, and changes involving the corrected QT dispersion were observed to parallel those of the uncorrected QT duration. Most previous studies have had to rely on ECG intervals measured manually. Manual measurement may have been subject to errors when the ECG parameters were measured during incremental atrial pacing. It was difficult to measure at a relatively rapid pacing rate (e.g. 100 bpm or 110 bpm) because the end of the T wave overlapped the next pacing spike and the P wave. In conclusion, QT dispersion of VT/VF patients was more prolonged at rest and at each incremental pacing rate than that of the other groups. QT dispersion in VT/VF patients decreased up to 100 bpm, but increased from 100 bpm, although that of the other groups did not change. References 1) Kuo CS, Munakata K, Reddy CP and Surawicz B : Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation 67: (1983) 2) Day CP, McComb JM and Campbell RW : QT dispersion : an indication of arrhythmia risk in patients with long QT intervals. Br Heart J 63: (1990) 3) Sporton SC, Taggart P, Sutton PM, Walker JM and Hardman SM : Acute ischaemia : a dynamic influence on QT dispersion. Lancet 349: (1997) 4) Bazett HC : An analysis of the time-relations of electrocardiograms. Heart 7 : (1920) 5) Linker NJ, Colonna P, Kekwick CA, Till J, Camm AJ and Ward DE : Assessment of QT dispersion in symptomatic patients with congenital long QT syndromes. Am J Cardiol 69: (1992) 6) Priori SG, Napolitano C, Diehl L and Schwartz PJ : Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome. Circulation 89: (1994) 7) Dritsas A, Gilligan D, Nihoyannopoulos P and Oakley CM : Amiodarone reduces QT dispersion in patients with hypertrophic cardiomyopathy. Int J Cardiol 36: (1992) 8) Buja G, Miorelli M, Turrini P, Melacini P and Nava A : Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol 72: (1993) 9) Galinier M, Vialette JC, Fourcade J, Cabrol P, Dongay B, Massabuau P, Boveda S, Doazan JP, Fauvel JM and Bounhoure JP : QT interval dispersion as a predictor of arrhythmic events in congestive heart failure. Importance of aetiology. Eur Heart J 19: (1998)

9 QT Alteration by Atrial Pacing ) Barr CS, Naas A, Freeman M, Lang CC and Struthers AD : QT dispersion and sudden unexpected death in chronic heart failure. Lancet 343: (1994) 11) Fu GS, Meissner A and Simon R : Repolarization dispersion and sudden cardiac death in patients with impaired left ventricular function. Eur Heart J 18 : (1997) 12) Leitch J, Basta M and Dobson A : QT dispersion does not predict early ventricular fibrillation after acute myocardial infarction. Pacing Clin Electrophysiol 18 : (1995) 13) Glancy JM, Garratt CJ, Woods KL and de Bono DP : QT dispersion and mortality after myocardial infarction. Lancet 345 : (1995) 14) Endoh Y, Kasanuki H, Ohnishi S and Uno M : Unsuitability of corrected QT dispersion as a marker for ventricular arrhythmias and cardiac sudden death after acute myocardial infarction. Jpn Circ J 63: (1999) 15) ZRoukema G, Singh JP, Meijs M, Carvalho C and Hart G : Effect of exercise-induced ischemia on QT interval dispersion. Am Heart J 135: (1998) 16) Kleber AG, Janse MJ, van Capelle FJ and Durrer D : Mechanism and time course of S-T and T-Q segment changes during acute regional myocardial ischemia in the pig heart determined by extracellular and intracellular recordings. Circ Res 42: (1978) 17) Morena H, Janse MJ, Fiolet JW, Krieger WJ, Crijns H and Durrer D : Comparison of the effects of regional ischemia, hypoxia, hyperkalemia, and acidosis on intracellular and extracellular potentials and metabolism in the isolated porcine heart. Circ Res 46: (1980) 18) Maceira-Coelho E, Monteiro F, da Conceicao JM, Cunha D, Cruz J, Almeida A and de Sousa T : Post-exercise changes of the Q-Tc interval in coronary heart disease. J Electrocardiol 16: (1983) 19) Egloff C, Merola P, Schiavon C, Schiavinato ML, Modena F, Stritoni P, Corbara F and Miraglia G : Sensitivity, specificity and predictive accuracy of Q wave, QX/QT ratio, QTc interval and ST depression during exercise testing in men with coronary artery disease. Am J Cardiol 60: (1987) 20) Gill JS, Baszko A, Xia R, Ward DE and Camm AJ : Dynamics of the QT interval in patients with exercise-induced ventricular tachycardia in normal and abnormal hearts. Am Heart J 126: (1993) 21) Yi G, Crook R, Guo XH, Staunton A, Camm AJ and Malik M : Exercise-induced changes in the QT interval duration and dispersion in patients with sudden cardiac death after myocardial infarction. Int J Cardiol 63: (1998) 22) Zabel M, Woosley RL and Franz MR : Is dispersion of ventricular repolarization rate dependent? Pacing Clin Electrophysiol 20 : (1997) 23) Simonson E, Cady LD and Woodbury M : The normal Q-T interval. Am Heart J 63 : (1962) 24) Ward DE : Prolongation of the QT interval as an indicator of risk of a cardiac event. Eur Heart J 9 (Suppl. G) : (1988) [Received March 29, 2002 : Accepted September 10, 2002]

QT Dispersion in Acute Myocardial Infarction with Special Reference to Left Ventriculographic Findings

QT Dispersion in Acute Myocardial Infarction with Special Reference to Left Ventriculographic Findings QT Dispersion in Acute Myocardial Infarction with Special Reference to Left Ventriculographic Findings Yoshitaka DOI, M.D., Kazuyuki TAKADA, M.D., Hiroyuki MIHARA, M.D., Tomoki KAWANO, M.D., Osamu NAKAGAKI,

More information

Paroxysmal Supraventricular Tachycardia PSVT.

Paroxysmal Supraventricular Tachycardia PSVT. Atrial Tachycardia; is the name for an arrhythmia caused by a disorder of the impulse generation in the atrium or the AV node. An area in the atrium sends out rapid signals, which are faster than those

More information

QT dispersion and RR variations on 12-lead ECGs in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy

QT dispersion and RR variations on 12-lead ECGs in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy European Heart Journal (1996) 17, 258-263 QT dispersion and RR variations on 12-lead ECGs in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy L. Fei, J. H. Goldman,

More information

ICD in a young patient with syncope

ICD in a young patient with syncope ICD in a young patient with syncope Konstantinos P. Letsas, MD, FESC Second Department of Cardiology Evangelismos General Hospital of Athens Athens, Greece Case presentation A 17-year-old apparently healthy

More information

20 ng/ml 200 ng/ml 1000 ng/ml chronic kidney disease CKD Brugada 5 Brugada Brugada 1

20 ng/ml 200 ng/ml 1000 ng/ml chronic kidney disease CKD Brugada 5 Brugada Brugada 1 Symposium 39 45 1 1 2005 2008 108000 59000 55 1 3 0.045 1 1 90 95 5 10 60 30 Brugada 5 Brugada 80 15 Brugada 1 80 20 2 12 X 2 1 1 brain natriuretic peptide BNP 20 ng/ml 200 ng/ml 1000 ng/ml chronic kidney

More information

Ablative Therapy for Ventricular Tachycardia

Ablative Therapy for Ventricular Tachycardia Ablative Therapy for Ventricular Tachycardia Nitish Badhwar, MD, FACC, FHRS 2 nd Annual UC Davis Heart and Vascular Center Cardiovascular Nurse / Technologist Symposium May 5, 2012 Disclosures Research

More information

REtrive. REpeat. RElearn Design by. Test-Enhanced Learning based ECG practice E-book

REtrive. REpeat. RElearn Design by. Test-Enhanced Learning based ECG practice E-book Test-Enhanced Learning Test-Enhanced Learning Test-Enhanced Learning Test-Enhanced Learning based ECG practice E-book REtrive REpeat RElearn Design by S I T T I N U N T H A N G J U I P E E R I Y A W A

More information

VENTRICULAR TACHYCARDIA WITH HEMODYNAMIC INSTABILITY REFRACTORY TO CARDIOVERSION: A CASE REPORT

VENTRICULAR TACHYCARDIA WITH HEMODYNAMIC INSTABILITY REFRACTORY TO CARDIOVERSION: A CASE REPORT VENTRCULAR TACHYCARDA WTH HEMODYNAMC NSTABLTY REFRACTORY TO CARDOVERSON: A CASE REPORT Chun-Jen Chou, 1 Chee-Siong Lee, 2,3 and Wen-Ter Lai 2,3 1 Department of Emergency Medicine, Kaohsiung Municipal Hsiao-Kang

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure (review

More information

Clinical and Electrocardiographic Characteristics of Patients with Brugada Syndrome: Report of Five Cases of Documented Ventricular Fibrillation

Clinical and Electrocardiographic Characteristics of Patients with Brugada Syndrome: Report of Five Cases of Documented Ventricular Fibrillation J Arrhythmia Vol 25 No 1 2009 Original Article Clinical and Electrocardiographic Characteristics of Patients with Brugada Syndrome: Report of Five Cases of Documented Ventricular Fibrillation Seiji Takashio

More information

Clinical Policy: Holter Monitors Reference Number: CP.MP.113

Clinical Policy: Holter Monitors Reference Number: CP.MP.113 Clinical Policy: Reference Number: CP.MP.113 Effective Date: 05/18 Last Review Date: 04/18 Coding Implications Revision Log Description Ambulatory electrocardiogram (ECG) monitoring provides a view of

More information

UNDERSTANDING YOUR ECG: A REVIEW

UNDERSTANDING YOUR ECG: A REVIEW UNDERSTANDING YOUR ECG: A REVIEW Health professionals use the electrocardiograph (ECG) rhythm strip to systematically analyse the cardiac rhythm. Before the systematic process of ECG analysis is described

More information

Step by step approach to EKG rhythm interpretation:

Step by step approach to EKG rhythm interpretation: Sinus Rhythms Normal sinus arrhythmia Small, slow variation of the R-R interval i.e. variation of the normal sinus heart rate with respiration, etc. Sinus Tachycardia Defined as sinus rhythm with a rate

More information

FANS Long QT Syndrome Investigation Protocol (including suspected mutation carriers)

FANS Long QT Syndrome Investigation Protocol (including suspected mutation carriers) Clinical Features FANS Long QT Syndrome Investigation Protocol (including suspected mutation carriers) History Syncope or presyncope compatible with ventricular tachyarrhythmia, especially relating to

More information

Sustained tachycardia with wide QRS

Sustained tachycardia with wide QRS Sustained tachycardia with wide QRS Courtesy from Prof. Antonio Américo Friedmann. Electrocardiology Service of University of Faculty of São Paulo. Opinions from colleagues Greetings to everyone, In a

More information

Simulation of T-Wave Alternans and its Relation to the Duration of Ventricular Action Potentials Disturbance

Simulation of T-Wave Alternans and its Relation to the Duration of Ventricular Action Potentials Disturbance The Open Pacing, Electrophysiology & Therapy Journal, 2010, 3, 21-27 21 Open Access Simulation of T-Wave Alternans and its Relation to the Duration of Ventricular Action Potentials Disturbance Dariusz

More information

Tachycardias II. Štěpán Havránek

Tachycardias II. Štěpán Havránek Tachycardias II Štěpán Havránek Summary 1) Supraventricular (supraventricular rhythms) Atrial fibrillation and flutter Atrial ectopic tachycardia / extrabeats AV nodal reentrant a AV reentrant tachycardia

More information

SEMINAIRES IRIS. Sudden cardiac death in the adult. Gian Battista Chierchia. Heart Rhythm Management Center, UZ Brussel. 20% 25% Cancers !

SEMINAIRES IRIS. Sudden cardiac death in the adult. Gian Battista Chierchia. Heart Rhythm Management Center, UZ Brussel. 20% 25% Cancers ! Sudden cardiac death in the adult Gian Battista Chierchia. Heart Rhythm Management Center, UZ Brussel.! " # $ % Cancers National Vital Statistics Report, Vol 49 (11), Oct. 12, 2001. 20% 25% State-specific

More information

ECG Cases and Questions. Ashish Sadhu, MD, FHRS, FACC Electrophysiology/Cardiology

ECG Cases and Questions. Ashish Sadhu, MD, FHRS, FACC Electrophysiology/Cardiology ECG Cases and Questions Ashish Sadhu, MD, FHRS, FACC Electrophysiology/Cardiology 32 yo female Life Insurance Physical 56 yo male with chest pain Terminology Injury ST elevation Ischemia T wave inversion

More information

Syncope in patients with inherited arrhythmogenic syndromes. Is it enough to justify ICD implantation?

Syncope in patients with inherited arrhythmogenic syndromes. Is it enough to justify ICD implantation? Innovations in Interventional Cardiology and Electrophysiology Thessaloniki 2014 Syncope in patients with inherited arrhythmogenic syndromes. Is it enough to justify ICD implantation? K. Letsas, MD, FESC

More information

Successful treatment of tachycardia-induced cardiomyopathy secondary to dual atrioventricular nodal nonreentrant tachycardia using cryoablation

Successful treatment of tachycardia-induced cardiomyopathy secondary to dual atrioventricular nodal nonreentrant tachycardia using cryoablation Successful treatment of tachycardia-induced cardiomyopathy secondary to dual atrioventricular nodal nonreentrant tachycardia using cryoablation Harold Rivner, MD, * Chris Healy, MD, Raul D. Mitrani, MD,

More information

Interpretation and Consequences of Repolarisation Changes in Athletes

Interpretation and Consequences of Repolarisation Changes in Athletes Interpretation and Consequences of Repolarisation Changes in Athletes Professor Sanjay Sharma E-mail sasharma@sgul.ac.uk @SSharmacardio Disclosures: None Athlete s ECG Vagotonia Sinus bradycardia Sinus

More information

Presenter Disclosure Information

Presenter Disclosure Information Various Morphological Types of Ventricular Premature Beats with Fragmented QRS Waves on 12 Lead Holter ECG had a Positive Relationship with Left Ventricular Fibrosis on CT in Patients with Hypertrophic

More information

Prevalence and QT Interval of Early Repolarization. in a Hospital-based Population

Prevalence and QT Interval of Early Repolarization. in a Hospital-based Population Original Article in a Hospital-based Population Hideki Hayashi MD PhD, Akashi Miyamoto MD, Katsuya Ishida MD, Tomohide Yoshino MD, Yoshihisa Sugimoto MD PhD, Makoto Ito MD PhD, Minoru Horie MD PhD Department

More information

NIH Public Access Author Manuscript Comput Cardiol (2010). Author manuscript; available in PMC 2011 July 11.

NIH Public Access Author Manuscript Comput Cardiol (2010). Author manuscript; available in PMC 2011 July 11. NIH Public Access Author Manuscript Published in final edited form as: Comput Cardiol (2010). 2010 September 26; 2010: 353 356. Torsadogenic Drug-induced Increased Short-term Variability of JT-area Xiao

More information

NAAMA s 24 th International Medical Convention Medicine in the Next Decade: Challenges and Opportunities Beirut, Lebanon June 26 July 2, 2010

NAAMA s 24 th International Medical Convention Medicine in the Next Decade: Challenges and Opportunities Beirut, Lebanon June 26 July 2, 2010 NAAMA s 24 th International Medical Convention Medicine in the Next Decade: Challenges and Opportunities Beirut, Lebanon June 26 July 2, 2010 I have a financial interest/arrangement or affiliation with

More information

EHRA Accreditation Exam - Sample MCQs Invasive cardiac electrophysiology

EHRA Accreditation Exam - Sample MCQs Invasive cardiac electrophysiology EHRA Accreditation Exam - Sample MCQs Invasive cardiac electrophysiology Dear EHRA Member, Dear Colleague, As you know, the EHRA Accreditation Process is becoming increasingly recognised as an important

More information

Advances in Ablation Therapy for Ventricular Tachycardia

Advances in Ablation Therapy for Ventricular Tachycardia Advances in Ablation Therapy for Ventricular Tachycardia Nitish Badhwar, MD, FACC, FHRS Director, Cardiac Electrophysiology Training Program University of California, San Francisco For those of you who

More information

ECG Interpretation Made Easy

ECG Interpretation Made Easy ECG Interpretation Made Easy Dr. A Tageldien Abdellah, MSc MD EBSC Lecturer of Cardiology- Hull University Hull York Medical School 2007-2008 ECG Interpretation Made Easy Synopsis Benefits Objectives Process

More information

CLINICAL INVESTIGATIONS. Methods

CLINICAL INVESTIGATIONS. Methods CLINICAL INVESTIGATIONS Jpn Circ J 2001; 65: 702 706 Correlation Between the Effective Refractory Period and Activation-Recovery Interval Calculated From the Intracardiac Unipolar Electrogram of Humans

More information

QT Interval: The Proper Measurement Techniques.

QT Interval: The Proper Measurement Techniques. In the name of God Shiraz E-Medical Journal Vol. 11, No. 2, April 2010 http://semj.sums.ac.ir/vol11/apr2010/88044.htm QT Interval: The Proper Measurement Techniques. Basamad Z*. * Assistant Professor,

More information

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012 IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT201203 JANUARY 24, 2012 The IHCP to reimburse implantable cardioverter defibrillators separately from outpatient implantation Effective March 1, 2012, the

More information

Comparison of different proarrhythmia biomarkers in isolated rabbit hearts

Comparison of different proarrhythmia biomarkers in isolated rabbit hearts Comparison of different proarrhythmia biomarkers in isolated rabbit hearts Summary of PhD Thesis Szabolcs Orosz, MSc Supervisor: Attila Farkas MD, PhD 2nd Dept. of Internal Medicine and Cardiology Centre

More information

Unusual Tachycardia Association In A patient Without Structural Heart Disease

Unusual Tachycardia Association In A patient Without Structural Heart Disease www.ipej.org 233 Case Report Unusual Tachycardia Association In A patient Without Structural Heart Disease Eduardo Arana-Rueda, Alonso Pedrote, Lorena Garcia-Riesco, Manuel Frutos-Lopez, Juan A. Sanchez-Brotons

More information

Basic Electrophysiology Protocols

Basic Electrophysiology Protocols Indian Journal of Cardiology ISSN-0972-1622 2012 by the Indian Society of Cardiology Vol. 15, (3-4), 27-37 [ 27 Review Article Shomu Bohora Assistant Professor, Deptt. of Cardiology, U.N. Mehta Institute

More information

Appendix D Output Code and Interpretation of Analysis

Appendix D Output Code and Interpretation of Analysis Appendix D Output Code and Interpretation of Analysis 8 Arrhythmia Code No. Description 8002 Marked rhythm irregularity 8110 Sinus rhythm 8102 Sinus arrhythmia 8108 Marked sinus arrhythmia 8120 Sinus tachycardia

More information

12-Lead ECG Interpretation. Kathy Kuznar, RN, ANP

12-Lead ECG Interpretation. Kathy Kuznar, RN, ANP 12-Lead ECG Interpretation Kathy Kuznar, RN, ANP The 12-Lead ECG Objectives Identify the normal morphology and features of the 12- lead ECG. Perform systematic analysis of the 12-lead ECG. Recognize abnormalities

More information

DR QAZI IMTIAZ RASOOL OBJECTIVES

DR QAZI IMTIAZ RASOOL OBJECTIVES PRACTICAL ELECTROCARDIOGRAPHY DR QAZI IMTIAZ RASOOL OBJECTIVES Recording of electrical events in heart Established electrode pattern results in specific tracing pattern Health of heart i. e. Anatomical

More information

The pill-in-the-pocket strategy for paroxysmal atrial fibrillation

The pill-in-the-pocket strategy for paroxysmal atrial fibrillation The pill-in-the-pocket strategy for paroxysmal atrial fibrillation KONSTANTINOS P. LETSAS, MD, FEHRA LABORATORY OF CARDIAC ELECTROPHYSIOLOGY EVANGELISMOS GENERAL HOSPITAL OF ATHENS ARRHYTHMIAS UPDATE,

More information

Please check your answers with correct statements in answer pages after the ECG cases.

Please check your answers with correct statements in answer pages after the ECG cases. ECG Cases ECG Case 1 Springer International Publishing AG, part of Springer Nature 2018 S. Okutucu, A. Oto, Interpreting ECGs in Clinical Practice, In Clinical Practice, https://doi.org/10.1007/978-3-319-90557-0

More information

The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia

The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia By Sandeep Joshi, MD and Jonathan S. Steinberg, MD Arrhythmia Service, Division of Cardiology

More information

Differences in the Slope of the QT-RR Relation Based on 24-Hour Holter ECG Recordings between Cardioembolic and Atherosclerotic Stroke

Differences in the Slope of the QT-RR Relation Based on 24-Hour Holter ECG Recordings between Cardioembolic and Atherosclerotic Stroke ORIGINAL ARTICLE Differences in the Slope of the QT-RR Relation Based on 24-Hour Holter ECG Recordings between Cardioembolic and Atherosclerotic Stroke Akira Fujiki 1 and Masao Sakabe 2 Abstract Objective

More information

EKG Competency for Agency

EKG Competency for Agency EKG Competency for Agency Name: Date: Agency: 1. The upper chambers of the heart are known as the: a. Atria b. Ventricles c. Mitral Valve d. Aortic Valve 2. The lower chambers of the heart are known as

More information

Arrhythmic Complications of MI. Teferi Mitiku, MD Assistant Clinical Professor of Medicine University of California Irvine

Arrhythmic Complications of MI. Teferi Mitiku, MD Assistant Clinical Professor of Medicine University of California Irvine Arrhythmic Complications of MI Teferi Mitiku, MD Assistant Clinical Professor of Medicine University of California Irvine Objectives Brief overview -Pathophysiology of Arrhythmia ECG review of typical

More information

Intraoperative and Postoperative Arrhythmias: Diagnosis and Treatment

Intraoperative and Postoperative Arrhythmias: Diagnosis and Treatment Intraoperative and Postoperative Arrhythmias: Diagnosis and Treatment Karen L. Booth, MD, Lucile Packard Children s Hospital Arrhythmias are common after congenital heart surgery [1]. Postoperative electrolyte

More information

Prediction of Life-Threatening Arrhythmia in Patients after Myocardial Infarction by Late Potentials, Ejection Fraction and Holter Monitoring

Prediction of Life-Threatening Arrhythmia in Patients after Myocardial Infarction by Late Potentials, Ejection Fraction and Holter Monitoring Prediction of Life-Threatening Arrhythmia in Patients after Myocardial Infarction by Late Potentials, Ejection Fraction and Holter Monitoring Yu-Zhen ZHANG, M.D.,* Shi-Wen WANG, M.D.,* Da-Yi Hu, M.D.,**

More information

Diploma in Electrocardiography

Diploma in Electrocardiography The Society for Cardiological Science and Technology Diploma in Electrocardiography The Society makes this award to candidates who can demonstrate the ability to accurately record a resting 12-lead electrocardiogram

More information

Case-Based Practical ECG Interpretation for the Generalist

Case-Based Practical ECG Interpretation for the Generalist Case-Based Practical ECG Interpretation for the Generalist Paul D. Varosy, MD, FACC, FAHA, FHRS Director of Cardiac Electrophysiology VA Eastern Colorado Health Care System Associate Professor of Medicine

More information

ECG ABNORMALITIES D R. T AM A R A AL Q U D AH

ECG ABNORMALITIES D R. T AM A R A AL Q U D AH ECG ABNORMALITIES D R. T AM A R A AL Q U D AH When we interpret an ECG we compare it instantaneously with the normal ECG and normal variants stored in our memory; these memories are stored visually in

More information

CME Article Brugada pattern masking anterior myocardial infarction

CME Article Brugada pattern masking anterior myocardial infarction Electrocardiography Series Singapore Med J 2011; 52(9) : 647 CME Article Brugada pattern masking anterior myocardial infarction Seow S C, Omar A R, Hong E C T Cardiology Department, National University

More information

at least 4 8 hours per week

at least 4 8 hours per week ECG IN ATHLETS An athlete is defined as an individual who engages in regular exercise or training for sport or general fitness, typically with a premium on performance, and often engaged in individual

More information

My Patient Needs a Stress Test

My Patient Needs a Stress Test My Patient Needs a Stress Test Amy S. Burhanna,, MD, FACC Coastal Cardiology Cape May Court House, New Jersey Absolute and relative contraindications to exercise testing Absolute Acute myocardial infarction

More information

Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh

Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh Arrhythmias and Heart Failure Ventricular Supraventricular VT/VF Primary prevention

More information

Introduction to Electrocardiography

Introduction to Electrocardiography Introduction to Electrocardiography Class Objectives: Introduction to ECG monitoring Discuss principles of interpretation Identify the components and measurements of the ECG ECG analysis ECG Monitoring

More information

QT Interval Dispersion Analysis in Acute Myocardial Infarction Patients: Coronary Reperfusion Effect

QT Interval Dispersion Analysis in Acute Myocardial Infarction Patients: Coronary Reperfusion Effect Article Original Article QT Interval Dispersion Analysis in Acute Myocardial Infarction Patients: Coronary Reperfusion Effect Neuza Helena Moreira Lopes, César Grupi, Cleberson H. Dina, Aécio F. T. de

More information

ECGs and Arrhythmias: Family Medicine Board Review 2009

ECGs and Arrhythmias: Family Medicine Board Review 2009 Rate Rhythm Intervals Hypertrophy ECGs and Arrhythmias: Family Medicine Board Review 2009 Axis Jess (Fogler) Waldura, MD University of California, San Francisco walduraj@nccc.ucsf.edu Ischemia Overview

More information

Chapter 20 (2) The Heart

Chapter 20 (2) The Heart Chapter 20 (2) The Heart ----------------------------------------------------------------------------------------------------------------------------------------- Describe the component and function of

More information

ECG Interpretation Cat Williams, DVM DACVIM (Cardiology)

ECG Interpretation Cat Williams, DVM DACVIM (Cardiology) ECG Interpretation Cat Williams, DVM DACVIM (Cardiology) Providing the best quality care and service for the patient, the client, and the referring veterinarian. GOAL: Reduce Anxiety about ECGs Back to

More information

Characteristics of the atrial repolarization phase of the ECG in paroxysmal atrial fibrillation patients and controls

Characteristics of the atrial repolarization phase of the ECG in paroxysmal atrial fibrillation patients and controls 672 Acta Cardiol 2015; 70(6): 672-677 doi: 10.2143/AC.70.6.3120179 [ Original article ] Characteristics of the atrial repolarization phase of the ECG in paroxysmal atrial fibrillation patients and controls

More information

ECGs and Arrhythmias: Family Medicine Board Review 2012

ECGs and Arrhythmias: Family Medicine Board Review 2012 Overview ECGs and Arrhythmias: Family Medicine Board Review 2012 Jess Waldura, MD University of California, San Francisco walduraj@nccc.ucsf.edu Bundle branch blocks Quick review of ischemia Arrhythmias

More information

Return to Basics. ECG Rate and Rhythm. Management of the Hospitalized Patient September 25, 2009

Return to Basics. ECG Rate and Rhythm. Management of the Hospitalized Patient September 25, 2009 Management of the Hospitalized Patient September 25, 2009 ECG Refresher and Update 2009 Return to Basics Determine rate and rhythm Determine intervals and axes Define morphology of P-QRS-T-U Compare with

More information

Case 1 Left Atrial Tachycardia

Case 1 Left Atrial Tachycardia Case 1 Left Atrial Tachycardia A 16 years old woman was referred to our institution because of recurrent episodes of palpitations and dizziness despite previous ablation procedure( 13 years ago) of postero-septal

More information

Return to Basics. Normal Intervals & Axes. ECG Rate and Rhythm

Return to Basics. Normal Intervals & Axes. ECG Rate and Rhythm Return to Basics Management of the Hospitalized Patient October 15, 2010 ECG Refresher and Update 2010 Determine rate and rhythm Determine intervals and axes Define morphology of P-QRS-T-U Compare with

More information

CRC 431 ECG Basics. Bill Pruitt, MBA, RRT, CPFT, AE-C

CRC 431 ECG Basics. Bill Pruitt, MBA, RRT, CPFT, AE-C CRC 431 ECG Basics Bill Pruitt, MBA, RRT, CPFT, AE-C Resources White s 5 th ed. Ch 6 Electrocardiography Einthoven s Triangle Chest leads and limb leads Egan s 10 th ed. Ch 17 Interpreting the Electrocardiogram

More information

QUESTION: In a patient with different QT intervals, which one will give the highest prognostic accuracy? REPLY:

QUESTION: In a patient with different QT intervals, which one will give the highest prognostic accuracy? REPLY: QUESTION: In a patient with different QT intervals, which one will give the highest prognostic accuracy? REPLY: First, there are two possibilities: I) It is not known, if the patient (subject) presented

More information

Index of subjects. effect on ventricular tachycardia 30 treatment with 101, 116 boosterpump 80 Brockenbrough phenomenon 55, 125

Index of subjects. effect on ventricular tachycardia 30 treatment with 101, 116 boosterpump 80 Brockenbrough phenomenon 55, 125 145 Index of subjects A accessory pathways 3 amiodarone 4, 5, 6, 23, 30, 97, 102 angina pectoris 4, 24, 1l0, 137, 139, 140 angulation, of cavity 73, 74 aorta aortic flow velocity 2 aortic insufficiency

More information

A Study to Determine if T Wave Alternans is a Marker of Therapeutic Efficacy in the Long QT Syndrome

A Study to Determine if T Wave Alternans is a Marker of Therapeutic Efficacy in the Long QT Syndrome A Study to Determine if T Wave Alternans is a Marker of Therapeutic Efficacy in the Long QT Syndrome A. Tolat A. Statement of study rationale and purpose T wave alternans (TWA), an alteration of the amplitude

More information

Study methodology for screening candidates to athletes risk

Study methodology for screening candidates to athletes risk 1. Periodical Evaluations: each 2 years. Study methodology for screening candidates to athletes risk 2. Personal history: Personal history of murmur in childhood; dizziness, syncope, palpitations, intolerance

More information

Signal-Averaged Electrocardiography (SAECG)

Signal-Averaged Electrocardiography (SAECG) Medical Policy Manual Medicine, Policy No. 21 Signal-Averaged Electrocardiography (SAECG) Next Review: April 2018 Last Review: April 2017 Effective: May 1, 2017 IMPORTANT REMINDER Medical Policies are

More information

Ventricular tachycardia and ischemia. Martin Jan Schalij Department of Cardiology Leiden University Medical Center

Ventricular tachycardia and ischemia. Martin Jan Schalij Department of Cardiology Leiden University Medical Center Ventricular tachycardia and ischemia Martin Jan Schalij Department of Cardiology Leiden University Medical Center Disclosure: Research grants from: Boston Scientific Medtronic Biotronik Sudden Cardiac

More information

QT Dispersion and T-Loop Morphology in Late Pregnancy and After Delivery

QT Dispersion and T-Loop Morphology in Late Pregnancy and After Delivery Physiol. Res. 51: 121-129, 2002 QT Dispersion and T-Loop Morphology in Late Pregnancy and After Delivery M. LECHMANOVÁ, O. KITTNAR, M. MLČEK, J. SLAVÍČEK, A. DOHNALOVÁ, Š. HAVRÁNEK, J. KOLAŘÍK, A. PAŘÍZEK

More information

Clinical Cardiac Electrophysiology

Clinical Cardiac Electrophysiology Clinical Cardiac Electrophysiology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of

More information

SUDDEN CARDIAC DEATH(SCD): Definition

SUDDEN CARDIAC DEATH(SCD): Definition SUDDEN CARDIAC DEATH EPIDEMIOLOGY, PATHOPHYSIOLOGY, PREVENTION & THERAPY Hasan Garan, M.D. Columbia University Medical Center SUDDEN CARDIAC DEATH(SCD): Definition DEATH DUE TO A CARDIAC CAUSE IN A CLINICALLY

More information

Index. cardiacep.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. cardiacep.theclinics.com. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A AEDs. See Automated external defibrillators (AEDs) AF. See Atrial fibrillation (AF) Age as factor in SD in marathon runners, 45 Antiarrhythmic

More information

Family Medicine for English language students of Medical University of Lodz ECG. Jakub Dorożyński

Family Medicine for English language students of Medical University of Lodz ECG. Jakub Dorożyński Family Medicine for English language students of Medical University of Lodz ECG Jakub Dorożyński Parts of an ECG The standard ECG has 12 leads: six of them are considered limb leads because they are placed

More information

Introduction to ECG Gary Martin, M.D.

Introduction to ECG Gary Martin, M.D. Brief review of basic concepts Introduction to ECG Gary Martin, M.D. The electrical activity of the heart is caused by a sequence of rapid ionic movements across cell membranes resulting first in depolarization

More information

Chapter 2 Practical Approach

Chapter 2 Practical Approach Chapter 2 Practical Approach There are beginners in electrocardiogram (ECG) analysis who are fascinated by a special pattern (e.g., a bundle-branch block or a striking Q wave) and thereby overlook other

More information

SUDDEN CARDIAC DEATH(SCD): Definition

SUDDEN CARDIAC DEATH(SCD): Definition SUDDEN CARDIAC DEATH EPIDEMIOLOGY, PATHOPHYSIOLOGY, PREVENTION & THERAPY Hasan Garan, M.D. Columbia University Medical Center SUDDEN CARDIAC DEATH(SCD): Definition DEATH DUE TO A CARDIAC CAUSE IN A CLINICALLY

More information

Cardiac Arrhythmias. Cathy Percival, RN, FALU, FLMI VP, Medical Director AIG Life and Retirement Company

Cardiac Arrhythmias. Cathy Percival, RN, FALU, FLMI VP, Medical Director AIG Life and Retirement Company Cardiac Arrhythmias Cathy Percival, RN, FALU, FLMI VP, Medical Director AIG Life and Retirement Company The Cardiovascular System Three primary functions Transport of oxygen, nutrients, and hormones to

More information

Journal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20.

Journal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20. Journal of the American College of Cardiology Vol. 37, No. 2, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)01133-5 Coronary

More information

Case Report Suppression of Frequent Ventricular Ectopy in a Patient with Hypertrophic Heart Disease with Ranolazine: A Case Report

Case Report Suppression of Frequent Ventricular Ectopy in a Patient with Hypertrophic Heart Disease with Ranolazine: A Case Report www.ipej.org 84 Case Report Suppression of Frequent Ventricular Ectopy in a Patient with Hypertrophic Heart Disease with Ranolazine: A Case Report David K. Murdock, MD 1,2 and Jeffrey W. Kaliebe, MT(ASCP),

More information

Atrial fibrillation (AF) is a disorder seen

Atrial fibrillation (AF) is a disorder seen This Just In... An Update on Arrhythmia What do recent studies reveal about arrhythmia? In this article, the authors provide an update on atrial fibrillation and ventricular arrhythmia. Beth L. Abramson,

More information

PERMANENT PACEMAKERS AND IMPLANTABLE DEFIBRILLATORS Considerations for intensivists

PERMANENT PACEMAKERS AND IMPLANTABLE DEFIBRILLATORS Considerations for intensivists PERMANENT PACEMAKERS AND IMPLANTABLE DEFIBRILLATORS Considerations for intensivists Craig A. McPherson, MD, FACC Associate Professor of Medicine Constantine Manthous, MD, FACP, FCCP Associate Clinical

More information

Chad Morsch B.S., ACSM CEP

Chad Morsch B.S., ACSM CEP What Is Cardiac Stress Testing? Chad Morsch B.S., ACSM CEP A Cardiac Stress Test is a test used to measure the heart's ability to respond to external stress in a controlled clinical environment. Cardiac

More information

Review Packet EKG Competency This packet is a review of the information you will need to know for the proctored EKG competency test.

Review Packet EKG Competency This packet is a review of the information you will need to know for the proctored EKG competency test. Review Packet EKG Competency 2015 This packet is a review of the information you will need to know for the proctored EKG competency test. Normal Sinus Rhythm Rhythm: Regular Ventricular Rate: 60-100 bpm

More information

Dispersion of myocardial repolarization contributes to arrhythmia

Dispersion of myocardial repolarization contributes to arrhythmia Imaging Dispersion of Myocardial Repolarization, I Comparison of Body-Surface and Epicardial Measures John E. Burnes, PhD; Raja N. Ghanem, MS; Albert L. Waldo, MD; Yoram Rudy, PhD Background Body-surface

More information

Paediatric ECG Interpretation

Paediatric ECG Interpretation Paediatric ECG Interpretation Dr Sanj Fernando (thanks to http://lifeinthefastlane.com/ecg-library/paediatric-ecginterpretation/) 3 yo boy complaining of abdominal pain and chest pain Child ECG vs Adult

More information

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac

More information

Synopsis of Management on Ventricular arrhythmias. M. Soni MD Interventional Cardiologist

Synopsis of Management on Ventricular arrhythmias. M. Soni MD Interventional Cardiologist Synopsis of Management on Ventricular arrhythmias M. Soni MD Interventional Cardiologist No financial disclosure Premature Ventricular Contraction (PVC) Ventricular Bigeminy Ventricular Trigeminy Multifocal

More information

TACHYARRHYTHMIAs. Pawel Balsam, MD, PhD

TACHYARRHYTHMIAs. Pawel Balsam, MD, PhD TACHYARRHYTHMIAs Pawel Balsam, MD, PhD SupraVentricular Tachycardia Atrial Extra Systole Sinus Tachycardia Focal A. Tachycardia AVRT AVNRT Atrial Flutter Atrial Fibrillation Ventricular Tachycardia Ventricular

More information

It is occasionally problematic to differentiate ST-segment

It is occasionally problematic to differentiate ST-segment CLINICAL INVESTIGATION Differential Diagnosis of Acute Pericarditis From Normal Variant Early Repolarization and Left Ventricular Hypertrophy With Early Repolarization: An Electrocardiographic Study Ravindra

More information

Chapter 16: Arrhythmias and Conduction Disturbances

Chapter 16: Arrhythmias and Conduction Disturbances Complete the following. Chapter 16: Arrhythmias and Conduction Disturbances 1. Cardiac arrhythmias result from abnormal impulse, abnormal impulse, or both mechanisms together. 2. is the ability of certain

More information

PATIENT WITH ARRHYTHMIA IN DENTIST S OFFICE. Małgorzata Kurpesa, MD., PhD. Chair&Department of Cardiology

PATIENT WITH ARRHYTHMIA IN DENTIST S OFFICE. Małgorzata Kurpesa, MD., PhD. Chair&Department of Cardiology PATIENT WITH ARRHYTHMIA IN DENTIST S OFFICE Małgorzata Kurpesa, MD., PhD. Chair&Department of Cardiology Medical University of Łódź The heart is made up of four chambers Left Atrium Right Atrium Left Ventricle

More information

EHRA/EUROPACE 2011 Madrid, Spain June

EHRA/EUROPACE 2011 Madrid, Spain June EHRA/EUROPACE 2011 Madrid, Spain June 26.-29.2011 Implementing modern management in atrial fibrillation patients Proceedings from the 3rd AFNet/EHRA consensus conference EHRA Special Session Different

More information

Risk Factors for Sudden cardiac Death

Risk Factors for Sudden cardiac Death Risk Factors for Sudden cardiac Death A. Arenal Arrhythmias in competitive sports Disclosure Conflict of interest Advisory board: Medtronic, Boston Scientific Research grants: Medtronic, Boston Scientific,

More information

MICS OF MYOCARDIAL ISCHEMIA AND INFARCTION REVISED FOR LAS VEGAS

MICS OF MYOCARDIAL ISCHEMIA AND INFARCTION REVISED FOR LAS VEGAS ECG MIMICS OF MYOCARDIAL ISCHEMIA AND INFARCTION 102.06.05 Tzong-Luen Wang MD, PhD, JM, FESC, FACC Professor. Medical School, Fu-Jen Catholic University Chief, Emergency Department, Shin-Kong Wu Ho-Su

More information

La valutazione dell atleta: è una strategia salva-vita e costo-efficace?

La valutazione dell atleta: è una strategia salva-vita e costo-efficace? La valutazione dell atleta: è una strategia salva-vita e costo-efficace? Primo trattato di Medicina Wilson and Jungner s criteria In the 1960s the World Health Organization adopted the Wilson and Jungner

More information

a lecture series by SWESEMJR

a lecture series by SWESEMJR Electrolyte disturbances Hypokalaemia Decreased extracellular potassium increases excitability in the myocardial cells and consequently the effect of very severe hypokalaemia is ventricular arrhythmia.

More information

Study Day 1 Study Days 2 to 9 Sequence 1 Placebo for moxifloxacin Study Days 2 to 8: placebo for pazopanib (placebopaz) 800 mg;

Study Day 1 Study Days 2 to 9 Sequence 1 Placebo for moxifloxacin Study Days 2 to 8: placebo for pazopanib (placebopaz) 800 mg; The study listed may include approved non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

Ekg pra pr c a tice D.HAMMOUDI.MD

Ekg pra pr c a tice D.HAMMOUDI.MD Ekg practice D.HAMMOUDI.MD Anatomy Revisited RCA (Right Coronary Artery) Right ventricle Inferior wall of LV Posterior wall of LV (75%) SA Node (60%) AV Node (>80%) LCA (Left Coronary Artery) Septal wall

More information